Long-Term Follow-Up of Breast Capsule Contracture Rates in Cosmetic and Reconstructive Cases

Abstract

Increased frequencies of capsular contracture were recorded in breast reconstruction that were not attributable to estrogen or menopausal status. On the basis of these results, the authors propose a follow-up period longer than 42 months and the inclusion of Baker grade II subjects.

Spider Silk Coatings as a Bioshield to Reduce Periprosthetic Fibrous Capsule Formation

“…One year after implantation, the cumulative risks associated with capsule formation further increases. [ 5 ] The underlying mechanisms of capsule contracture development have been discussed controversially in literature. [ 6 ] Amongst the reasons for late capsule contracture, missing biocompatibility of the implanted material seems to play a prominent role, besides clinical factors such as infections, postoperative hematomas or seromes.…”

Povidone-Iodine Combined With Antibiotic Topical Irrigation to Reduce Capsular Contracture in Cosmetic Breast Augmentation

“…Interestingly, the case of CC in the topical antibiotics group occurred approximately 4 months after a dental procedure treated without an oral antibiotic prophylaxis. A recent report recommends a follow-up period longer than 42 months and the inclusion of Baker grade II subjects in CC analyses, 44 but we believe our results were not altered by our modified scale or the fact that we only analyzed patients with Baker grade III or IV CC.…”

Influence of patient age on capsular contracture after aesthetic breast augmentation

“…However, there is a paucity of data to support this theory. Recent long-term studies indicate there may be a cumulative risk for the development of Baker III and IV capsules (16)(17)(18). Known risk factors, such as operative technique, hematoma (1,11), bacterial infections and biofilm development, especially with Staphylococcus epidermidis or Pseudomonas species, are most likely to impact early capsular development (19-22); however, very little is known about the factors that may influence the long-term cumulative risk.…”

“…Known risk factors, such as operative technique, hematoma (1,11), bacterial infections and biofilm development, especially with Staphylococcus epidermidis or Pseudomonas species, are most likely to impact early capsular development (19-22); however, very little is known about the factors that may influence the long-term cumulative risk. Marques et al (18) showed a cumulative risk of Baker III/IV capsules in long-term follow-up from 7% in the first two years to 10% over an eight-year period. They also found an increased risk for capsular contracture in women who underwent their primary surgery when they were >54 years of age.…”